SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus

by Jordana Muñoz-Basagoiti, Daniel Perez-Zsolt, Jorge Carrillo, Julià Blanco, Bonaventura Clotet, Nuria Izquierdo-Useros
Published 2021-01-01

Variation around the dominant viral genome sequence contributes to viral load and outcome in patients with Ebola virus disease

by Xiaofeng Dong, Jordana Munoz-Basagoiti, Natasha Y. Rickett, Georgios Pollakis, William A. Paxton, Stephan Günther, Romy Kerber, Lisa F. P. Ng, Michael J. Elmore, N’faly Magassouba, Miles W. Carroll, David A. Matthews, Julian A. Hiscox
Published 2020-09-01

Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen

by Jordi Rodon, Jordana Muñoz-Basagoiti, Daniel Perez-Zsolt, Marc Noguera-Julian, Marc Noguera-Julian, Roger Paredes, Roger Paredes, Lourdes Mateu, Carles Quiñones, Carles Perez, Itziar Erkizia, Ignacio Blanco, Alfonso Valencia, Alfonso Valencia, Víctor Guallar, Víctor Guallar, Jorge Carrillo, Julià Blanco, Julià Blanco, Julià Blanco, Joaquim Segalés, Joaquim Segalés, Bonaventura Clotet, Bonaventura Clotet, Bonaventura Clotet, Júlia Vergara-Alert, Nuria Izquierdo-Useros, Nuria Izquierdo-Useros
Published 2021-03-01